Bortezomib News

Latest News On Bortezomib

Daratumumab Confirmed as SOC for AL Amyloidosis

Daratumumab Confirmed as SOC for AL Amyloidosis

12/17/2024 6:55 AM

FDA Expands Darzalex Faspro Indication in Myeloma

FDA Expands Darzalex Faspro Indication in Myeloma

8/1/2024 1:43 AM

Myeloma: First-in-Class ADC Regimen Yields Key Benefits

Myeloma: First-in-Class ADC Regimen Yields Key Benefits

6/7/2024 4:33 AM

$New Agent Shows Early Promise in Triple-Class Refractory Multiple Myeloma$

New Agent Shows Early Promise in Triple-Class Refractory Multiple Myeloma

4/17/2024 6:26 AM

Render Time: 2025-02-14 17:29:49